Table 4.
Procedural variable patients with concomitant CABG/AV surgery
| Characteristics | Total CABG/AV cohort (n=5867) n (%) |
Male (n=3937) n (%) |
Female (n=1928) n (%) |
P values |
| Type of procedure | 0.168 | |||
| Repair | 50 (0.9) | 29 (0.7) | 21 (1.1) | |
| Replacement | 5815 (99.1) | 3908 (99.3) | 1907 (98.9) | |
| Type of implant | < 0.001 | |||
| Bioprosthesis unstented | 259 (4.4) | 157 (4.0) | 100 (5.2) | |
| Bioprosthesis stented | 4465 (76.1) | 2896 (73.6) | 1568 (81.3) | |
| Bioprosthesis unknown | 1093 (18.6) | 0 (0.0) | 1 (0.1) | |
| Mechanical | 238 (4.1) | 853 (21.7) | 238 (12.3) | |
| Homograft | 2 (0.03) | 2 (0.1) | 0 (0.0) | |
| Autograft | 0 (0.0) | 0 (0.0) | 0 (0.0) | |
| Type of graft | ||||
| Total arterial graft | 1456 (24.8) | 902 (22.9) | 554 (28.7) | < 0.001 |
| Total venous graft | 1613 (27.5) | 1035 (26.3) | 578 (30.0) | < 0.001 |
| Utilisation of both arterial and venous graft | 2794 (47.6) | 1999 (50.8) | 795 (41.2) | < 0.001 |
| EuroSCORE | ||||
| Additive EuroSCORE | 6.9±2.6 (0–20) | 6.5±2.6 (0–20) | 7.8±2.3 (3–20) | < 0.001 |
| Logistic EuroSCORE | 9.0±8.9 (1–87) | 8.2±8.9 (1–85) | 10.5±8.6 (2–87) | < 0.001 |
| Outcome | ||||
| Hospital mortality | 134 (3.4) | 105 (5.4) | 239 (4.1) | < 0.001 |
Significant values are depicted in bold.
AV, aortic valve; CABG, coronary artery bypass graft.